Early palliative care for patients with metastatic non-small-cell lung cancer.
暂无分享,去创建一个
Alona Muzikansky | Craig D Blinderman | Thomas J Lynch | J. Temel | T. Lynch | A. Muzikansky | J. Greer | V. Jackson | C. Blinderman | W. Pirl | J. Jacobsen | E. Gallagher | J. Billings | Jennifer S Temel | Joseph A Greer | Emily R Gallagher | Sonal Admane | Vicki A Jackson | Constance M Dahlin | Juliet Jacobsen | William F Pirl | J Andrew Billings | S. Admane | C. Dahlin | Victoria Jackson
[1] R. Stephens,et al. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] The Hospital Anxiety And Depression Scale , 1986, Health and quality of life outcomes.
[3] M. Parmar,et al. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] P. Brown,et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[6] C. Benedetti,et al. NCCN clinical practice guidelines in oncology: palliative care. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[8] S. Asch,et al. Evidence-based recommendations for information and care planning in cancer care. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Milton C Weinstein,et al. Comparative effectiveness and health care spending--implications for reform. , 2010, The New England journal of medicine.
[10] D. Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. , 1995, Lung cancer.
[11] E. Emanuel,et al. Managed care, hospice use, site of death, and medical expenditures in the last year of life. , 2002, Archives of internal medicine.
[12] J. Temel,et al. Components of early intervention outpatient palliative care consultation in patients with incurable NSCLC. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[14] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[15] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[16] I. Tannock,et al. Effectiveness of specialized palliative care: a systematic review. , 2008, JAMA.
[17] C. Earle,et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Souhami,et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life , 2004, Thorax.
[19] E. Bruera,et al. Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] D. M. Stith. Slowing the growth of health care costs. , 2008, The New England journal of medicine.
[21] P. Fayers,et al. Quality of life in palliative cancer care: results from a cluster randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. Tang,et al. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Mark T Hegel,et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. , 2009, JAMA.
[24] S. Mcphee,et al. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. , 2004, Archives of internal medicine.
[25] David Cella,et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. , 2002, Journal of the National Cancer Institute.
[26] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[27] T. Ferris,et al. Options for slowing the growth of health care costs. , 2008, The New England journal of medicine.
[28] J. Temel,et al. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] R. Heist,et al. Code Status Documentation in the Outpatient Electronic Medical Records of Patients with Metastatic Cancer , 2010, Journal of General Internal Medicine.
[30] D. Cella. The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer. , 2004, Seminars in oncology.
[31] H. Prigerson,et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. , 2008, Psychosomatics.
[32] R. Stephens,et al. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. , 1995, British Journal of Cancer.
[33] L. Kachnic,et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital. , 2001, Journal of palliative medicine.
[34] S. Barni,et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] G. Rodin,et al. Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] M. Jiroutek,et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] A. Gregor,et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Benjamin Movsas,et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] T. Morita,et al. Late referrals to specialized palliative care service in Japan. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] D. Cella,et al. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. , 2002, Journal of clinical epidemiology.